New nanoparticle drug combination for atherosclerosis developed

Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

Thwarting deadly heart blockages with organic nanoparticles

Cardiovascular disease, which kills one Australian every 12 minutes, is caused by a hardening of the arteries due to abnormal deposits of fat and cholesterol (known as plaque) in the inner lining of the artery; a process ...

New nano-polymer could prevent heart failure

Researchers at Ben-Gurion University (BGU) and the Sheba Medical Center have developed a new therapy to treat atherosclerosis and prevent heart failure with a new biomedical polymer that reduces arterial plaque and inflammation ...